Ruth Halaban

20.0k total citations · 3 hit papers
155 papers, 12.1k citations indexed

About

Ruth Halaban is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Ruth Halaban has authored 155 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 61 papers in Cell Biology and 46 papers in Oncology. Recurrent topics in Ruth Halaban's work include melanin and skin pigmentation (55 papers), Melanoma and MAPK Pathways (35 papers) and RNA regulation and disease (18 papers). Ruth Halaban is often cited by papers focused on melanin and skin pigmentation (55 papers), Melanoma and MAPK Pathways (35 papers) and RNA regulation and disease (18 papers). Ruth Halaban collaborates with scholars based in United States, Israel and Italy. Ruth Halaban's co-authors include Gisela Moellmann, Seymour H. Pomerantz, Elaine Cheng, Harriet M. Kluger, Byoung S. Kwon, Michael Krauthammer, Antonella Bacchiocchi, Andrew Baird, Sikha Ghosh and Mario Sznol and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Ruth Halaban

154 papers receiving 11.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma

2011 534 citations Michael Krauthammer, Ruth Halaban et al. profile →
Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure

2015 396 citations Antonella Bacchiocchi, Ruth Halaban et al. profile →
Integrated NY-ESO-1 antibody and CD8⁺T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

2011 254 citations Mario Sznol, Ruth Halaban et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruth Halaban United States	58	7.0k	4.3k	3.5k	2.4k	1.5k	155	12.1k
Colin R. Goding United Kingdom	62	8.0k 1.1×	4.1k 0.9×	2.5k 0.7×	2.0k 0.8×	1.2k 0.8×	153	11.7k
Lionel Larue France	56	7.8k 1.1×	3.3k 0.8×	2.7k 0.8×	1.3k 0.6×	549 0.4×	174	11.4k
Hans R. Widlund United States	39	6.4k 0.9×	2.5k 0.6×	2.3k 0.6×	1.4k 0.6×	477 0.3×	59	8.9k
Estela E. Medrano United States	38	5.9k 0.9×	1.8k 0.4×	1.8k 0.5×	1.3k 0.5×	465 0.3×	81	10.3k
Toru Miki United States	37	6.6k 0.9×	2.8k 0.7×	2.0k 0.6×	957 0.4×	219 0.1×	77	9.2k
Martin McMahon United States	72	12.9k 1.9×	1.9k 0.4×	7.2k 2.0×	2.7k 1.1×	191 0.1×	167	17.9k
Marcus Bosenberg United States	61	7.0k 1.0×	1.4k 0.3×	4.7k 1.3×	3.6k 1.5×	161 0.1×	177	12.6k
Philip S. Rudland United Kingdom	59	7.2k 1.0×	1.6k 0.4×	2.6k 0.7×	1.2k 0.5×	277 0.2×	251	10.3k
Graham Carpenter United States	60	7.5k 1.1×	2.0k 0.5×	3.8k 1.1×	1.2k 0.5×	283 0.2×	120	11.7k
Allan Balmain United States	64	12.5k 1.8×	2.1k 0.5×	7.8k 2.2×	1.3k 0.5×	112 0.1×	204	18.4k

Countries citing papers authored by Ruth Halaban

Since Specialization

Citations

This map shows the geographic impact of Ruth Halaban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Halaban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Halaban more than expected).

Fields of papers citing papers by Ruth Halaban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Halaban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Halaban. The network helps show where Ruth Halaban may publish in the future.

Co-authorship network of co-authors of Ruth Halaban

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Halaban. A scholar is included among the top collaborators of Ruth Halaban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Halaban. Ruth Halaban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Su, David, David A. Schoenfeld, Raysa Cabrejo, et al.. (2024). Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma. Journal for ImmunoTherapy of Cancer. 12(3). e008646–e008646. 4 indexed citations

Shaked, Yuval, Madeleine Benguigui, Ruth Halaban, et al.. (2023). A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non–small-cell lung cancer and melanoma.. Journal of Clinical Oncology. 41(16_suppl). 2557–2557. 1 indexed citations

Weber, Jeffrey S., Mario Sznol, Ryan J. Sullivan, et al.. (2017). A Serum Protein Signature Associated with Outcome after Anti–PD-1 Therapy in Metastatic Melanoma. Cancer Immunology Research. 6(1). 79–86. 53 indexed citations

Boddupalli, Chandra Sekhar, Noffar Bar, Krishna Kadaveru, et al.. (2016). Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells. JCI Insight. 1(21). 111 indexed citations

Robles‐Espinoza, Carla Daniela, Nicola D. Roberts, Shuyang Chen, et al.. (2016). Germline MC1R status influences somatic mutation burden in melanoma. Nature Communications. 7(1). 12064–12064. 87 indexed citations

Biezuner, Tamir, Adam Spiro, Rivka Adar, et al.. (2016). A generic, cost-effective, and scalable cell lineage analysis platform. Genome Research. 26(11). 1588–1599. 28 indexed citations

Scortegagna, Marzia, Eric Lau, Tongwu Zhang, et al.. (2015). PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets. Cancer Research. 75(7). 1399–1412. 44 indexed citations

Jilaveanu, Lucia B., Fabio Parisi, Meaghan L. Barr, et al.. (2014). PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis. Clinical Cancer Research. 21(9). 2138–2147. 57 indexed citations

Ha, Byung Hak, Matthew J. Davis, Catherine Chen, et al.. (2012). Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate. Proceedings of the National Academy of Sciences. 109(40). 16107–16112. 66 indexed citations

10.

Shi, Hubing, Gatien Moriceau, Xiangju Kong, et al.. (2012). Preexisting MEK1 Exon 3 Mutations in V600E/K BRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors. Cancer Discovery. 2(5). 414–424. 75 indexed citations

11.

Singhal, Garima, Sebastian Szpakowski, Christina Ivins Zito, et al.. (2011). Phosphoproteomic Screen Identifies Potential Therapeutic Targets in Melanoma. Molecular Cancer Research. 9(6). 801–812. 73 indexed citations

12.

Kluger, Harriet M., Kathleen Hoyt, Antonella Bacchiocchi, et al.. (2011). Plasma Markers for Identifying Patients with Metastatic Melanoma. Clinical Cancer Research. 17(8). 2417–2425. 77 indexed citations

13.

Halaban, Ruth, Michael Krauthammer, Mattia Pelizzola, et al.. (2009). Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications. PLoS ONE. 4(2). e4563–e4563. 50 indexed citations

14.

Kluger, Harriet M., Kyle A. DiVito, Aaron J. Berger, et al.. (2004). Her2/neu is not a commonly expressed therapeutic target in melanoma – a large cohort tissue microarray study. Melanoma Research. 14(3). 207–210. 36 indexed citations

15.

Hoek, Keith S., David L. Rimm, Kenneth R. Williams, et al.. (2004). Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas. Cancer Research. 64(15). 5270–5282. 371 indexed citations

16.

Halaban, Ruth, Elaine Cheng, Yoel Smicun, & Joseph Germino. (2000). Deregulated E2f Transcriptional Activity in Autonomously Growing Melanoma Cells. The Journal of Experimental Medicine. 191(6). 1005–1016. 68 indexed citations

17.

Cohen, Tzafra, Hela Gitay-Goren, Masabumi Shibuya, et al.. (1995). VEGF121, a Vascular Endothelial Growth Factor (VEGF) Isoform Lacking Heparin Binding Ability, Requires Cell-surface Heparan Sulfates for Efficient Binding to the VEGF Receptors of Human Melanoma Cells. Journal of Biological Chemistry. 270(19). 11322–11326. 218 indexed citations

18.

Halaban, Ruth. (1993). Growth Regulation in Normal and Malignant Melanocytes. Recent results in cancer research. 128. 133–150. 13 indexed citations

19.

Kwon, Byoung S., et al.. (1988). Sequence analysis of mouse tyrosinase cDNA and the effect of melanotropin on its gene expression. Biochemical and Biophysical Research Communications. 153(3). 1301–1309. 141 indexed citations

20.

Boissy, Raymond E. & Ruth Halaban. (1985). Establishment of Proliferative, Pure Cultures of Pigmented Chicken Melanocytes from Neural Tubes. Journal of Investigative Dermatology. 84(2). 158–161. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact